Bioactivity:

Olmutinib is an orally available small molecule, a mutant-selective inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Olmutinib binds to and inhibits mutant forms of EGFR, thereby leading to cell death of EGFR-ex

CAS nr:

1353550-13-6

Purity:

98%

Molecular Weight:

486,59

SMILES:

CN1CCN(CC1)c1ccc(cc1)Nc1nc2c(c(n1)Oc1cccc(c1)NC(=O)C=C)scc2

Formula:

C26H26N6O2S

Pathway:

Angiogenesis,Tyrosine Kinase/Adaptors,JAK/STAT signaling,Tyrosine Kinase/Adaptors,Angiogenesis

Target:

BTK,BTK,EGFR,EGFR,EGFR